Literature DB >> 2168202

Antiviral drug sensitivity in ocular herpes simplex virus infection.

M J Menage1, E de Clercq, A van Lierde, V S Easty, J M Darville, S D Cook, D L Easty.   

Abstract

Thirty-nine herpes simplex virus (HSV) isolates were assayed for their sensitivity to 10 different antiviral agents. Of these 39 HSV isolates 10 were cultured from recipient buttons obtained at penetrating keratoplasty in patients with inactive stromal scarring due to recurrent herpetic keratitis, 25 were cultured from patients with conjunctival and ulcerative ocular infections, and the remaining four were laboratory strains with known drug sensitivity patterns, thus providing controls for the experiment. All but one of the 35 clinical isolates of HSV were type 1 and all were sensitive to the 10 antiviral agents. A single type 2 isolate from a young man with recurrent conjunctivitis proved to be resistant to a number of the antiviral agents. Since many of the clinical isolates had been exposed to multiple and protracted antiviral drug treatment, it is suggested that antiviral drug resistance in type 1 HSV ocular infection is not a significant problem.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168202      PMCID: PMC1042201          DOI: 10.1136/bjo.74.9.532

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  19 in total

1.  Adenine arabinoside in the management of herpetic keratitis.

Authors:  J I McGill; D Coster; T Frauenfelder; A D Holt-Wilson; H Williams; B R Jones
Journal:  Trans Ophthalmol Soc U K       Date:  1975-07

2.  Isolation of herpes simplex virus from the cornea in chronic stromal keratitis.

Authors:  C Shimeld; A B Tullo; D L Easty; J Thomsitt
Journal:  Br J Ophthalmol       Date:  1982-10       Impact factor: 4.638

3.  Acyclovir.

Authors:  M C Timbury
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-30

4.  A miniaturised and simplified technique for typing and subtyping herpes simplex virus.

Authors:  J M Darville
Journal:  J Clin Pathol       Date:  1983-08       Impact factor: 3.411

5.  Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.

Authors:  E De Clercq; J Descamps; G Verhelst; R T Walker; A S Jones; P F Torrence; D Shugar
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

Review 6.  Drugs five years later: acyclovir.

Authors:  D I Dorsky; C S Crumpacker
Journal:  Ann Intern Med       Date:  1987-12       Impact factor: 25.391

7.  The role of herpesvirus type 1 thymidine kinase in experimental ocular infections.

Authors:  Y J Gordon; J A Armstrong; S I Brown; Y Becker
Journal:  Am J Ophthalmol       Date:  1983-02       Impact factor: 5.258

8.  Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo.

Authors:  H J Field; G Darby
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

9.  Use of acyclovir in herpetic ocular infection.

Authors:  J McGill; P Tormey
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

10.  Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.

Authors:  P C Maudgal; E De Clercq; P Huyghe
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-02       Impact factor: 4.799

View more
  3 in total

Review 1.  Herpes simplex virus in the eye.

Authors:  S D Cook
Journal:  Br J Ophthalmol       Date:  1992-06       Impact factor: 4.638

2.  The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin.

Authors:  M Halberstadt; M Machens; K-A Gahlenbek; M Böhnke; J G Garweg
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

Review 3.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.